These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

963 related articles for article (PubMed ID: 32232449)

  • 1. Geographic Distribution of Racial Differences in Prostate Cancer Mortality.
    Fletcher SA; Marchese M; Cole AP; Mahal BA; Friedlander DF; Krimphove M; Kilbridge KL; Lipsitz SR; Nguyen PL; Choueiri TK; Kibel AS; Trinh QD
    JAMA Netw Open; 2020 Mar; 3(3):e201839. PubMed ID: 32232449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Access to Prostate-Specific Antigen Testing and Mortality Among Men With Prostate Cancer.
    Iyer HS; Stone BV; Roscoe C; Hsieh MC; Stroup AM; Wiggins CL; Schumacher FR; Gomez SL; Rebbeck TR; Trinh QD
    JAMA Netw Open; 2024 Jun; 7(6):e2414582. PubMed ID: 38833252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Income inequality and treatment of African American men with high-risk prostate cancer.
    Ziehr DR; Mahal BA; Aizer AA; Hyatt AS; Beard CJ; D Amico AV; Choueiri TK; Elfiky A; Lathan CS; Martin NE; Sweeney CJ; Trinh QD; Nguyen PL
    Urol Oncol; 2015 Jan; 33(1):18.e7-18.e13. PubMed ID: 25306287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Black Race With Prostate Cancer-Specific and Other-Cause Mortality.
    Dess RT; Hartman HE; Mahal BA; Soni PD; Jackson WC; Cooperberg MR; Amling CL; Aronson WJ; Kane CJ; Terris MK; Zumsteg ZS; Butler S; Osborne JR; Morgan TM; Mehra R; Salami SS; Kishan AU; Wang C; Schaeffer EM; Roach M; Pisansky TM; Shipley WU; Freedland SJ; Sandler HM; Halabi S; Feng FY; Dignam JJ; Nguyen PL; Schipper MJ; Spratt DE
    JAMA Oncol; 2019 Jul; 5(7):975-983. PubMed ID: 31120534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Racial disparities in prostate cancer-specific mortality in men with low-risk prostate cancer.
    Mahal BA; Aizer AA; Ziehr DR; Hyatt AS; Choueiri TK; Hu JC; Hoffman KE; Sweeney CJ; Beard CJ; D'Amico AV; Martin NE; Kim SP; Trinh QD; Nguyen PL
    Clin Genitourin Cancer; 2014 Oct; 12(5):e189-95. PubMed ID: 24861952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Racial and Ethnic Disparities in Prostate Cancer Outcomes in the Veterans Affairs Health Care System.
    Yamoah K; Lee KM; Awasthi S; Alba PR; Perez C; Anglin-Foote TR; Robison B; Gao A; DuVall SL; Katsoulakis E; Wong YN; Markt SC; Rose BS; Burri R; Wang C; Aboiralor O; Fink AK; Nickols NG; Lynch JA; Garraway IP
    JAMA Netw Open; 2022 Jan; 5(1):e2144027. PubMed ID: 35040965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disparities in treatment patterns and mortality in prostate cancer: Interaction between Black race and end-stage kidney disease.
    Sarabu N; Dong W; Koroukian SM
    Cancer Med; 2024 May; 13(10):e7027. PubMed ID: 38770622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Racial disparity and socioeconomic status in association with survival in older men with local/regional stage prostate carcinoma: findings from a large community-based cohort.
    Du XL; Fang S; Coker AL; Sanderson M; Aragaki C; Cormier JN; Xing Y; Gor BJ; Chan W
    Cancer; 2006 Mar; 106(6):1276-85. PubMed ID: 16475208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in mortality among Black and White men with prostate cancer in Massachusetts and Pennsylvania: Race and neighborhood socioeconomic position.
    Iyer HS; Gomez SL; Chen JT; Trinh QD; Rebbeck TR
    Cancer; 2021 Jul; 127(14):2525-2534. PubMed ID: 33798264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neighborhood Deprivation, Race and Ethnicity, and Prostate Cancer Outcomes Across California Health Care Systems.
    Wadhwa A; Roscoe C; Duran EA; Kwan L; Haroldsen CL; Shelton JB; Cullen J; Knudsen BS; Rettig MB; Pyarajan S; Nickols NG; Maxwell KN; Yamoah K; Rose BS; Rebbeck TR; Iyer HS; Garraway IP
    JAMA Netw Open; 2024 Mar; 7(3):e242852. PubMed ID: 38502125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Relative Importance of Race Compared to Health Care and Social Factors in Predicting Prostate Cancer Mortality: A Random Forest Approach.
    Hanson HA; Martin C; O'Neil B; Leiser CL; Mayer EN; Smith KR; Lowrance WT
    J Urol; 2019 Dec; 202(6):1209-1216. PubMed ID: 31246547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Racial Disparities in the Presentation, Early Definitive Surgical Treatment, and Mortality Among Men Diagnosed with Poorly Differentiated/Undifferentiated Non-metastatic Prostate Cancer in the USA.
    Lediju O; Ikuemonisan J; Salami SS; Adejoro O
    J Racial Ethn Health Disparities; 2019 Apr; 6(2):401-408. PubMed ID: 30506310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate Cancer Among Black Men in Canada.
    Albers P; Bashir S; Mookerji N; Broomfield S; Martín AM; Ghosh S; Kinnaird A
    JAMA Netw Open; 2024 Jun; 7(6):e2418475. PubMed ID: 38916889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultraviolet index and racial differences in prostate cancer incidence and mortality.
    Taksler GB; Cutler DM; Giovannucci E; Smith MR; Keating NL
    Cancer; 2013 Sep; 119(17):3195-203. PubMed ID: 23744754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective study of the serum prostate specific antigen concentrations and Gleason histologic scores of black and white men with prostate carcinoma.
    Fowler JE; Bigler SA
    Cancer; 1999 Sep; 86(5):836-41. PubMed ID: 10463983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regional Variation in Active Surveillance for Low-Risk Prostate Cancer in the US.
    Washington SL; Jeong CW; Lonergan PE; Herlemann A; Gomez SL; Carroll PR; Cooperberg MR
    JAMA Netw Open; 2020 Dec; 3(12):e2031349. PubMed ID: 33369661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in the Incidence of Fatal Prostate Cancer in the United States by Race.
    Kelly SP; Rosenberg PS; Anderson WF; Andreotti G; Younes N; Cleary SD; Cook MB
    Eur Urol; 2017 Feb; 71(2):195-201. PubMed ID: 27476048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Racial Difference in Prostate Cancer Cell Telomere Lengths in Men with Higher Grade Prostate Cancer: A Clue to the Racial Disparity in Prostate Cancer Outcomes.
    Heaphy CM; Joshu CE; Barber JR; Davis C; Zarinshenas R; De Marzo AM; Lotan TL; Sfanos KS; Meeker AK; Platz EA
    Cancer Epidemiol Biomarkers Prev; 2020 Mar; 29(3):676-680. PubMed ID: 31915143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mediators of Racial Disparity in the Use of Prostate Magnetic Resonance Imaging Among Patients With Prostate Cancer.
    Leapman MS; Dinan M; Pasha S; Long J; Washington SL; Ma X; Gross CP
    JAMA Oncol; 2022 May; 8(5):687-696. PubMed ID: 35238879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of type of definitive treatment on race-based differences in prostate cancer-specific survival.
    Frego N; Labban M; Stone BV; Koelker M; Alkhatib K; Lughezzani G; Buffi NM; Lipsitz SR; Weissman JS; Fletcher SA; Kibel AS; Trinh QD; Cole AP
    Prostate; 2023 Aug; 83(11):1099-1111. PubMed ID: 37150867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.